Laidlaw Group, LLC: AXP position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Laidlaw Group, LLC on AXP, newest first. How the timeline and the estimate are built.
Laidlaw Group, LLC held 0 AXP shares at 2015-03-31 per its 13F-HR filed 2015-05-01.
the latest 13F is the newest step
- period ended2015-03-3113F 0 sharesChange vs previous 13F -2,371 shares
13F-HR 0001062993-15-002323 filed by Laidlaw Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2014-12-3113F 2,371 sharesChange vs previous 13F 0 shares
0.11% of the 13F portfolio, value $221,000.
13F-HR 0001062993-15-000506 filed by Laidlaw Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2014-09-3013F 2,371 sharesChange vs previous 13F -400 shares
0.1% of the 13F portfolio, value $208,000.
13F-HR 0001062993-14-006420 filed by Laidlaw Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2014-06-3013F 2,771 sharesChange vs previous 13F 0 shares
0.13% of the 13F portfolio, value $263,000.
13F-HR 0001062993-14-004255 filed by Laidlaw Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2014-03-3113F 2,771 sharesChange vs previous 13F -780 shares
0.13% of the 13F portfolio, value $249,000.
13F-HR 0001062993-14-002457 filed by Laidlaw Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2013-12-3113F 3,551 sharesChange vs previous 13F not available
0.17% of the 13F portfolio, value $322,000.
13F-HR 0001062993-14-000399 filed by Laidlaw Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).